Incyte Stock Investor Sentiment

INCY Stock  USD 73.52  1.80  2.51%   
Slightly above 60% of all Incyte's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Incyte suggests that some traders are interested. Incyte's investing sentiment can be driven by a variety of factors including economic data, Incyte's earnings reports, geopolitical events, and overall market trends.

Panic Vs Confidence

60

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Incyte's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Incyte.

Incyte Historical Sentiment

Although Incyte's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Incyte, such as negative comments on social media and news outlets, may cause fear in the market and push Incyte's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Incyte.
  

Incyte Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Incyte can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Incyte Historical Investor Sentiment

Investor biases related to Incyte's public news can be used to forecast risks associated with an investment in Incyte. The trend in average sentiment can be used to explain how an investor holding Incyte can time the market purely based on public headlines and social activities around Incyte. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Incyte's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Incyte and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Incyte news discussions. The higher the estimate score, the more favorable the investor's outlook on Incyte.
over three weeks ago at simplywall.st         
Incyte shareholders have earned a 24 percent return over the last year
Simply Wall St News at Macroaxis
over a month ago at businesswire.com         
Incyte Named One of Top 5 Companies on Science Magazines 2024 Top Employers List
businesswire News
over a month ago at businesswire.com         
Incyte Named One of Top 5 Companies on Science Magazines 2024 Top Employers List
businesswire News
over a month ago at finance.yahoo.com         
GPCR drugmaker Septerna amasses 288M in IPO
Yahoo News
over a month ago at finance.yahoo.com         
Incyte Named One of Top 5 Companies on Science Magazines 2024 Top Employers List
Yahoo News
over a month ago at finance.yahoo.com         
Non-melanoma Skin Cancer is Predicted to Exhibit Remarkable Growth During the Study Period DelveInsi...
Yahoo News
over a month ago at finance.yahoo.com         
Bioprocessing Market Size Worth 72.55 Billion, Globally, by 2031 - Exclusive Report by The Insight P...
Yahoo News
over a month ago at thelincolnianonline.com         
Incyte Co. Stock Holdings Lowered by Inspire Advisors LLC
news
over a month ago at finance.yahoo.com         
China Medical SystemFirst Ruxolitinib Creams Prescriptions for Vitiligo Issued in the Greater Bay Ar...
Yahoo News
over a month ago at kalkinemedia.com         
Innovent Announces Phase 2 Clinical Study of Picankibart in Chinese Patients with Ulcerative Colitis...
news
over a month ago at gurufocus.com         
State Street Corps Strategic Reduction in Incyte Corp Holdings
Gurufocus Stories at Macroaxis
over a month ago at finance.yahoo.com         
Innovent Announces Phase 2 Clinical Study of Picankibart in Chinese Patients with Ulcerative Colitis...
Yahoo News
over a month ago at finance.yahoo.com         
Innovent Announces Phase 2 Clinical Study of Picankibart in Chinese Patients with Ulcerative Colitis...
Yahoo News
over a month ago at finance.yahoo.com         
Knight Therapeutics Announces Approval of Minjuvi in Mexico
Yahoo News
over a month ago at thelincolnianonline.com         
Incyte Co. Position Lessened by Inspire Investing LLC
news
Far too much social signal, news, headlines, and media speculation about Incyte that are available to investors today. That information is available publicly through Incyte media outlets and privately through word of mouth or via Incyte internal channels. However, regardless of the origin, that massive amount of Incyte data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Incyte news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Incyte relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Incyte's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Incyte alpha.

Incyte Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 382 shares by Thomas Tray of Incyte at 63.37 subject to Rule 16b-3
09/13/2024
2
Disposition of 2136 shares by Sheila Denton of Incyte at 67.63 subject to Rule 16b-3
10/11/2024
3
China Medical SystemFirst Ruxolitinib Creams Prescriptions for Vitiligo Issued in the Greater Bay Area
10/18/2024
4
Incyte Hits New 12-Month High Whats Next
10/29/2024
5
MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results
11/05/2024
6
Acquisition by Flannelly Barry P of 2256 shares of Incyte at 68.62 subject to Rule 16b-3
11/08/2024
7
Atopic Dermatitis Drugs Market to Grow by USD 6.2 Billion , Driven by High Prevalence of the Condition, AI-Powered Report Explores Market Evolution - Technavio
11/13/2024
8
ARMISTICE CAPITAL, LLC Acquires Significant Stake in Eyenovia Inc
11/15/2024
9
Is Incyt Corporation the Best Immunotherapy Stock to Buy Now
11/18/2024
10
ASX set to slip, global markets fall on rising Russia-Ukraine tensions
11/19/2024
11
Incyte Co. Shares Sold by Connor Clark Lunn Investment Management Ltd.
11/20/2024
12
Top Research Reports for GE Aerospace, Fomento Economico Waste Management
11/22/2024

Additional Tools for Incyte Stock Analysis

When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.